Shares of QuantumPh-P fell more than 6% in the morning trading session as the company is an AI drug enterprise, and CICC expects it to enter the Shanghai Stock Exchange in the near future.

QUANTUMPH-P(02228) fell more than 6% in the morning, and as of the time of writing, it was down 1.64%, trading at HK$5.4, with a turnover of HK$2.4 million.

It was reported that QUANTUMPH-P(QuantumPharma) is a pioneering research and development platform enterprise based on quantum physics and artificial intelligence to drive robots. Its main businesses include drug discovery solutions and intelligent automation solutions. Among them, drug discovery solutions can provide solutions for different modules across the whole process of drug discovery and research, and intelligent automation solutions mainly include solid-state R&D services and automated chemical synthesis services.

China Securities reported that after the close of trading on August 16, Hang Seng Index Company will announce the half-year review results of Hang Seng series indices, including Hang Seng, H-share, Hang Seng Tech, etc., as well as Hang Seng Composite Index closely related to H-share and Hang Seng Composite Index. China Securities expects that 25 companies will be included in the H-share Connect, including QUANTUMPH-P.